Advising ProductLige Group and its majority shareholder 21 invest on the acquisition from Galiena Capital of AxPharma group, a prominent pharmacovigilance service provider in Europe.
The group refinances its debt alongside securing the means to achieve the next steps of its acceleration and transformation plan.
Founded in 2001 by Florence Postel and accompanied by Galiena Capital as majority shareholder since 2015, Axpharma is a prominent pharmacovigilance service provider in Europe. Its team of experts enjoys a strong reputation for providing highly dependable services in the areas of case management, medical writing, medical literature monitoring, pharmacovigilance responsibility delegation, and around-the-clock medical information. Its clients include pharmaceutical, biopharmaceutical, medical device and cosmetics companies, primarily in Europe.
This acquisition will support the Group’s ambition to become the leading global provider of regulatory and compliance services in life sciences, covering regulatory affairs, clinical safety, pharmacovigilance, and quality.